The disclosure in some aspects relates to recombinant adeno associated viruses having distinct tissue targeting capabilities. In some aspects the disclosure relates to gene transfer methods using the recombinant adeno associated viruses. In some aspects the disclosure relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.